Lineage Cell Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.

About LCTX

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.

CEO

Brian M. Culley

CEOBrian M. Culley

Employees

Employees77

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

1990

Founded1990

Employees

Employees77

LCTX Key Statistics

Market cap

207.16M

Market cap207.16M

Price-Earnings ratio

-11.39

Price-Earnings ratio-11.39

Dividend yield

—

Dividend yield—

Average volume

6.40M

Average volume6.40M

High today

$0.9575

High today$0.9575

Low today

$0.85

Low today$0.85

Open price

$0.9039

Open price$0.9039

Volume

3.51M

Volume3.51M

52 Week high

$1.15

52 Week high$1.15

52 Week low

$0.3651

52 Week low$0.3651

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own LCTX. This list is generated using Robinhood data, and it’s not a recommendation.